AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
A quick guide outlining which cryptocurrency to buy first, focusing on accessibility, liquidity, and practical use cases for newcomers.
24,236 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Redwire posted a strong revenue beat but a bigger-than-expected loss, triggering a mid-day rally in its stock. This a...
A prominent institutional investor revealed a sizable Callaway Golf stake as the stock surged. This article breaks do...
Promotional events like Prime Day grab headlines, but the real driver of Amazon stock is its cloud arm, AWS. This gui...
A fresh SEC filing shows AREX Capital Management opening a new stake in CALY with 453,000 shares worth about $5.29 mi...
Nike stands as a global powerhouse, but recent pressure has investors asking, should Nike stock? This guide lays out ...
Meta Platforms has shown business momentum even as its stock traded lower. This guide weighs the case to buy, sell, o...
Curious about a long term reason to own Pfizer? This guide lays out a practical, actionable case for buying and holdi...
Ackman's bold pivot away from Alphabet toward AI bets has investors talking. This guide breaks down what happened, wh...
AST SpaceMobile just completed a trio of successful BlueBird launches, yet spacemobile's stock down after the event. ...
Sea Limited entertained investors with strong earnings yet faced a dramatic intraday drop driven by rising fintech co...
A dramatic 41% weekly jump has investors buzzing about Infleqtion. Learn what fueled the move, how to evaluate quantu...